Cytiva, a global life sciences leader, has partnered with Mycenax Biotech Inc, a leading biopharmaceutical CDMO company, to launch Taiwan’s first continuous bioprocessing lab.
Biotech Cleanroom Industry Articles
Artiva Biotherapeutics Builds New US Cell Therapy R&D and Manufacturing Facility
Artiva Biotherapeutics, an oncology company specializing in primary allogeneic natural killer (NK) cell therapies to treat cancer, announced on Aug. 12, 2021 an expansion of its US presence with a new R&D and GMP manufacturing facility in San Diego, Calif., for cell therapies.
Rentschler Biopharma lays the foundation stone for a new US production facility in the greater Boston area
New facility at the existing facility in Milford, MA, USA will significantly expand cGMP manufacturing capabilities and accelerate the clinical and commercial supply of vital biopharmaceuticals
Alzheimer’s Disease Study Suggests Viral Beginnings
More than a century after its discovery, no effective prevention or treatment exists for this progressive deterioration of brain tissue, memory and identity. With more people living to older ages, there is a growing need to clarify Alzheimer’s disease risk factors and disease mechanisms and use this information to find new ways in which to treat and prevent this terrible disorder.
The beating brain: A video captures the organ’s rhythmic pulsations
A study recently published in the journal Magnetic Resonance in Medicine and co-authored by Stanford life-science research assistant Itamar Terem, then-postdoc Samantha Jane Holdsworth, PhD, (now at the University of Auckland) and several other Stanford colleagues describes a new imaging method that, by means of a kind of strobe-action amplification technique, is able to visually blow up the minute heartbeat-induced pulsations of the brain to produce mind-boggling video sequences such as the one you’ve hopefully taken a peek at here.
Neovii & Mundipharma Agreement for Solid Organ & Stem Cell Transplant
Neovii pharmaceuticals AG of Rapperswil, Switzerland and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon®, in China and Japan from end October.
ACROMEC Healthcare Pharma Cleanroom Contract Worth $6.2M
ACROMEC Limited (“ACROMEC”, SGX:43F), an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biomedical, research and academia sectors, has secured three new contracts totaling approximately S6.2 million.
Dynacure secures €47 million financing to advance lead program into clinical development
Dynacure, a biotechnology company developing new treatments for patients affected by serious orphan disorders, announced today the completion of a €47 million financing round (~US$55 million) to advance its lead program into clinical development. Andera Partners (formerly Edmond de Rothschild Investment Partners) led the financing round, joined by Pontifax, Bpifrance, Kurma Partners and IdInvest Partners.
Pharmaceutical Plant in Skidel to Open in October
pharmaceutical plant in Skidel (Grodno Oblast) will be launched in October, the press service of the Council of Republic told BelTA following the meeting between Speaker, curator of the Belarusian-Indian cooperation Mikhail Myasnikovich and Indian investors Jayant Kaushik, Alok Kumar (Lok-Beta Pharmaceuticals (I) Pvt. Ltd) and Director of OOO Novalok Kumar Manoranjan.
R&D Operations Hub to Open in Chengdu, China
R&D Operations Hub to Open in Chengdu, China Sanofi to further accelerate its scientific presence with the opening...
Catalent Signs Agreement To Acquire Juniper Pharmaceuticals, Inc.
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has agreed to acquire Juniper Pharmaceuticals, Inc. (NASDAQ: JNPR), including its Nottingham, U.K.-based Juniper Pharma Services division.
Biosensor Chips based on Copper and Graphene Oxide
Russian researchers from the Moscow Institute of Physics and Technology have developed biosensor chips of unprecedented sensitivity, which are based on copper instead of the conventionally used gold. Besides making the device somewhat cheaper, this innovation will facilitate the manufacturing process.